Cue Biopharma (CUE) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.91
Average-0.9755
Median-0.9600
Minimum-1.09
Maximum-0.9000
-0.91
Past Month+0.18 (16.51%)
The P/E ratio for Cue Biopharma (CUE) is -0.91 as of Jun 13, 2025. This represents a decrease of -17.27% compared to its 12-month average P/E ratio of -1.1. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Cue Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cue Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cue Biopharma to industry peers.
Cue Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cue Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cue Biopharma to industry peers.
Cue Biopharma (CUE) P/E Ratio Insights
See Cue Biopharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Cue Biopharma (CUE)
Order type
Buy in
Order amount
Est. shares
0 shares
Cue Biopharma (CUE) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $0.6528 | -0.98 |
| May 1, 2025 | $0.7518 | -1.00 |
| Apr 1, 2025 | $0.75 | -1.00 |
| Mar 3, 2025 | $1.20 | -1.32 |
| Feb 3, 2025 | $1.41 | -1.56 |
| Jan 2, 2025 | $1.09 | -1.20 |
Cue Biopharma (CUE) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.91 | -24.17% |
| 2024 | -1.20 | -45.45% |
| 2023 | -2.20 | +6.80% |
| 2022 | -2.06 | -74.28% |
| 2021 | -8.01 | +0.50% |
| 2020 | -7.97 | — |
FAQs About Cue Biopharma (CUE) P/E ratio
The latest P/E ratio of Cue Biopharma (CUE) is -0.91, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Cue Biopharma’s last 12-month average P/E ratio is -1.1, compared to its current P/E ratio of -0.91. This reflects a decrease of -17.27%.
Cue Biopharma’s current P/E ratio of -0.91 is lower than its last 12-month average P/E of -1.1. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Cue Biopharma’s average P/E ratio over the last 3 years is -1.82. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Cue Biopharma’s average P/E ratio over the last 5 years is -4.3. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.